Compounds and compositions as modulators of GPR119 activity

Details for Australian Patent Application No. 2009217359 (hide)

Owner IRM LLC

Inventors Michellys, Pierre-Yves; Alper, Phillip; Epple, Robert; Cow, Christopher; Mutnick, Daniel

Agent Davies Collison Cave

Pub. Number AU-B-2009217359

PCT Pub. Number WO2009/105715

Priority 61/030,907 22.02.08 US

Filing date 20 February 2009

Wipo publication date 27 August 2009

Acceptance publication date 1 September 2011

International Classifications

C07D 207/12 (2006.01) Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

A61K 31/402 (2006.01) - 1-aryl-substituted, e.g. piretanide

A61P 3/00 (2006.01) Drugs for disorders of the metabolism

C07D 403/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

Event Publications

9 September 2010 PCT application entered the National Phase

  PCT publication WO2009/105715 Priority application(s): WO2009/105715

1 September 2011 Application Accepted

  Published as AU-B-2009217359

12 January 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009217361-Compounds and compositions as modulators of GPR119 activity

2009217356-Heterocyclic compounds and compositions as c-kit and PDGFR kinase inhibitors